Sep 30, 2021

Featuring an interview with Dr Samuel J Klempner, including the following topics:

• Advances in immune checkpoint inhibitor therapy for gastroesophageal cancers (0:00)
• Evolving treatment landscape of HER2-positive gastroesophageal cancers (16:38)
• New options for later-line treatment of gastroesophageal cancers...

Sep 29, 2021

Featuring perspectives from Dr David F McDermott, including the following topics:

Introduction (0:00)

Case: A woman in her early 70s with metastatic clear cell renal cell carcinoma (ccRCC) and a severe psychiatric history — Ranju Gupta, MD (10:45)

Case: A man in his late 40s with metastatic ccRCC with sarcomatoid...

Sep 28, 2021

Featuring perspectives from Drs Alexey V Danilov, Susan O’Brien, Sonali M Smith and Julie M Vose, moderated by Matthew S Davids, including the following topics:

• Introduction (0:00)
• Therapeutic Algorithms for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia (CLL) — Susan O’Brien, MD (0:58)
• Spectrum,...

Sep 27, 2021

Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Hepatocellular Carcinoma and Pancreatic Cancer — Faculty Presentation 3: Optimal Management of Localized and Advanced Pancreatic Cancer — Dr O’Reilly

CME information and select...

Sep 27, 2021

Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Hepatocellular Carcinoma and Pancreatic Cancer — Faculty Presentation 4: New Data Sets Investigating Novel Treatment Strategies for Advanced Biliary Tract Cancers — Dr Bekaii-Saab

CME information and select...